JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, S.-N.
Right arrow Articles by Lo, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, S.-N.
Right arrow Articles by Lo, Y.-C.

Vol. 292, Issue 1, 188-195, January 2000

Characterization of Tetrandrine-Induced Inhibition of Large-Conductance Calcium-Activated Potassium Channels in a Human Endothelial Cell Line (HUV-EC-C)1

Sheng-Nan Wu, Hui-Fang Li and Yi-Ching Lo

Department of Medical Education and Research, Veterans General Hospital-Kaohsiung (S.-N.W., H.-F.L.); and Department of Pharmacology, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China (Y.-C.L.)

The effects of tetrandrine, a blocker of voltage-dependent Ca2+ channels, on ionic currents were investigated in an endothelial cell line (HUV-EC-C) originally derived from human umbilical vein. In whole-cell configuration, tetrandrine (0.5-50 µM) reversibly decreased the amplitude of K+ outward currents. The IC50 value of tetrandrine-induced decrease in outward current was 5 µM. The K+ outward current in response to depolarizing voltage pulses was also inhibited by iberiotoxin (200 nM), yet not by glibenclamide (10 µM) or apamin (200 nM). The reduced amplitude of outward current by tetrandrine can be reversed by the further addition of Evans' blue (30 µM) or niflumic acid (30 µM). Thus, the tetrandrine-sensitive component of outward current is believed to be Ca2+-activated K+ current. Pretreatment with thapsigargin (1 µM) or sodium nitroprusside (10 µM) for 5 h did not prevent tetrandrine-mediated inhibition of outward current. In outside-out configuration, bath application of tetrandrine (5 µM) did not change the single-channel conductance but significantly reduced the opening probability of large-conductance Ca2+-activated K+ (BKCa) channels. The tetrandrine-mediated decrease in the channel activity was independent on internal Ca2+ concentration. Tetrandrine (5 µM) can also shift the activation curve of BKCa channels to more positive potentials by approximately 20 mV. The change in the kinetic behavior of BKCa channels caused by tetrandrine is due to a decrease in mean open time and an increase in mean closed time. The present study provides substantial evidence that tetrandrine is capable of suppressing the activity of BKCa channels in endothelial cells. The direct inhibition of these channels by tetrandrine should contribute to its effect on the functional activities of endothelial cells.


1 This work was supported by grants from the Department of Health (DOH-85-CM-041), National Science Council (NSC-87-2341-B075B-013), and Veterans General Hospital-Kaohsiung (VGHNSU-87-06 and VGHKS-88-31), Taiwan, Republic of China.


0022-3565/0/2921-0188$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Zeng, E. Gordon, Z. Lin, I. M. Lozinskaya, R. N. Willette, and X. Xu
1-[1-Hexyl-6-(methyloxy)-1H-indazol-3-yl]-2-methyl-1-propanone, a Potent and Highly Selective Small Molecule Blocker of the Large-Conductance Voltage-Gated and Calcium-Dependent K+ Channel
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 168 - 177.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S.-N. Wu, S.-I. Liu, and M.-H. Huang
Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH3 Cells and Pheochromocytoma PC12 Cells
Endocrinology, March 1, 2004; 145(3): 1175 - 1184.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.